The Swiss pharmaceutical firm says the acquisition would complement its current pipeline of therapies for neuromuscle problems.
Source link
Novartis Agrees to Acquire Avidity Biosciences for $12 Billion
Related Posts
States See a Federal Power Grab in Clash Over AI Data Centers
The Trump administration needs to regulate how knowledge facilities connect with the facility grid. Source link
Millions of Coders Love This AI Startup. Can It Last?
Cursor, which launched one of many fastest-growing AI instruments of all time, is on the heart of the boom-or-bust debate…
Nvidia Unveils Faster AI Chips Sooner Than Expected
On the Client Electronics Present in Las Vegas, CEO Jensen Huang stated extra highly effective chips will allow coaching of…